FEATURE ARTICLES
FDA's complementary pilot could help weed through a persistent examination backlog, but uncertainty and upheaval in leadership at the top puts its future in question.
- Closing The MES Value Gap: Why Technology Isn't The Problem
- Makary's Exit Raises New Questions About FDA Stability And Direction
- Why Isolators Do Not Automatically Ensure Annex 1 Compliance
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- [Video] Get It Right with The Gemba
- April 2026 — CDMO Opportunities And Threats Report
- GLP-1 Receptor Agonists: Metabolism, Reward Biology, And AI-Driven Drug Discovery
PHARMA ONLINE WHITE PAPERS
-
![Labculture Shielded Biological Safety Cabinet]( "Shielded BSCs: Regulatory Requirement Or Risk-Based Engineering Solution?")
Shielded BSCs: Regulatory Requirement Or Risk-Based Engineering Solution?Master the balance between USP <825> aseptic standards and radiation safety. Learn how integrated engineering solutions ensure regulatory compliance while protecting both patients and personnel.
-
IP Considerations In Drug Development For Biotech Companies4/20/2026
Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.
-
Simplify CAPA In 7 Steps9/20/2024
Discover how to streamline corrective action/preventive action (CAPA) management in regulatory environments in 7 steps.
-
Isolate Bright GFP-Expressing HEK293 Cells For Cell Line Development Workflow11/7/2025
Explore a high-efficiency workflow for isolating and expanding GFP-expressing HEK293 cells that enables stable, bright clones ideal for imaging and tracking to simplify clonal development.
-
Global Regulatory Harmonization: Comparisons In Aseptic Barrier Systems4/20/2026
Compare global aseptic standards from the FDA, EMA, PIC/S, and WHO. Gain insights into how advanced barrier systems harmonize international requirements to ensure sterile product integrity and safety.
-
Why Pharmaceutical Scientists Trust The Discovery Core Rheometer5/1/2026
Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Efficient Protein Purification Strategies
- Mitigating Powder Flow And Static Issues Using SYLOID® Mesoporous Silica
- Advancements In GLP-1 Analog Formulation: Overcoming Challenges
- Performance Comparison Of The Vericheck ddPCR™ Empty-Full Capsid Kit And Analytical Ultracentrifugation (AUC)
- A Novel Patient-Derived Colorectal Cancer Organoid Platform
NEWSLETTER ARCHIVE
- 05.19.26 -- How Rheology Strengthens Every Stage of Pharma Development
- 05.19.26 -- How Generic Pharma Manufacturers Can Rebuild Margins Inside The Four Walls
- 05.19.26 -- Avoid Sterilization Failures: Key Challenges, EO Guidance, And Validation Basics
- 05.18.26 -- Inspection Innovations Shaping Quality Across Pharma Manufacturing
- 05.18.26 -- Selecting a Sustainable CDMO Partner for your Small Molecule Program
INDUSTRY NEWS
-
![rating service, satisfaction-GettyImages-2221603596]( "ISPE Announces 2026 FOYA Winners")
ISPE Announces 2026 FOYA WinnersThese awards recognize pharmaceutical and biopharmaceutical manufacturing projects that demonstrate excellence across innovation, operations, supply chain, Pharma 4.0, and social impact.
-
![FDA Logo on phone screen-GettyImages-2208861549]( "Høeg In, Pazdur Out At The FDA")
Høeg In, Pazdur Out At The FDAWhat an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
-
![business peope negotiating-GettyImages-637902194]( "9 Drugs Granted Fast Track By FDA's Voucher Program")
9 Drugs Granted Fast Track By FDA's Voucher ProgramWith targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
![Pharmaceutical sorting machine, pills-GettyImages-1499814881]( "Leaders In The Excipient Market: Region And Type")
Leaders In The Excipient Market: Region And TypeThough North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
![GettyImages-2189405678-GLP-1-obesity]( "Pfizer Strengthens Obesity Foothold With Metsera Acquisition")
Pfizer Strengthens Obesity Foothold With Metsera AcquisitionAfter discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery5/12/2026
Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), the medicine performance‑enhancing company, today announced that it has signed an exclusivity agreement with a U.S. biopharmaceutical company (Nasdaq listed, Mcap USD 1Bn+) for the application of Nanoform’s proprietary biologics nanoparticle technology to support the development of differentiated subcutaneous biologic medicines.
-
Compact & Powerful Double Planetary Mixer For Lab And Pilot-Scaling4/30/2026
ROSS has delivered an ergonomic and powerful Double Planetary Mixer Model DPM-10 engineered for high-viscosity and specialty material processing in laboratory and pilot-scale operations.
-
AES Cleanroom Technology appoints John Groth As Chief Revenue Officer4/27/2026
AES Cleanroom Technology, a leading provider of modular cleanroom design, manufacturing, and construction solutions for the life sciences and biopharmaceutical industries, has appointed John Groth as Chief Revenue Officer as demand grows for flexible, high-performance manufacturing environments across pharma and biotech.
